BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15893919)

  • 1. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates.
    Nerurkar J; Jun HW; Price JC; Park MO
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):56-68. PubMed ID: 15893919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled-release tablet matrices from carrageenans: compression and dissolution studies.
    Hariharan M; Wheatley TA; Price JC
    Pharm Dev Technol; 1997 Nov; 2(4):383-93. PubMed ID: 9552467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
    Vostalová L; Rabisková M; Medvecká G
    Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
    Patel N; Madan P; Lin S
    Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Eur J Pharm Biopharm; 2004 Jul; 58(1):51-9. PubMed ID: 15207537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions.
    Cao QR; Choi HG; Kim DC; Lee BJ
    Int J Pharm; 2004 Apr; 274(1-2):107-17. PubMed ID: 15072787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
    Karavas E; Georgarakis E; Bikiaris D
    Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading, and co-active on drug release.
    Ebube NK; Hikal AH; Wyandt CM; Beer DC; Miller LG; Jones AB
    Pharm Dev Technol; 1997 May; 2(2):161-70. PubMed ID: 9552442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroretentive drug delivery systems with L-dopa based on carrageenans and hydroxypropylmethylcellulose.
    Dorożyński P; Kulinowski P; Mendyk A; Jachowicz R
    Int J Pharm; 2011 Feb; 404(1-2):169-75. PubMed ID: 21095225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.
    Ribeiro L; Ferreira DC; Veiga FJ
    J Control Release; 2005 Mar; 103(2):325-39. PubMed ID: 15763617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and in vitro evaluation of prednisolone buccoadhesive tablets.
    Mohammadi-Samani S; Bahri-Najafi R; Yousefi G
    Farmaco; 2005 Apr; 60(4):339-44. PubMed ID: 15848210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
    Odeku OA; Fell JT
    J Pharm Pharmacol; 2004 Nov; 56(11):1365-70. PubMed ID: 15525442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of theophylline sustained release dosage form based on Kollidon SR.
    Reza MS; Quadir MA; Haider SS
    Pak J Pharm Sci; 2002 Jan; 15(1):63-70. PubMed ID: 16414869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
    Felician WA; Ghaly ES
    Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.